FTC alleges influential transgender health organization misled parents about safety of youth treatments
The Federal Trade Commission (FTC) and four Republican-led states sued the World Professional Association for Transgender Health (WPATH) on Wednesday, alleging the influential medical organization misled parents and doctors about the safety, effectiveness and necessity of transgender medical treatments for minors.
The lawsuit alleges WPATH, whose standards of care are widely used by physicians treating patients with gender dysphoria, made deceptive claims about puberty blockers, cross-sex hormones and sex change surgeries while failing to adequately disclose potential risks and side effects.
“Parents have a right to make informed decisions about their children’s health,” FTC Chairman Andrew Ferguson wrote on X. “The FTC will not allow parents and children to be deceived by medical organizations and providers who are prioritizing profit over children’s health and safety.”
‘TRANSGENDER MADNESS’ UNDER FIRE AFTER CONGRESS LETS TAXPAYER FUNDING BAN LAPSE
According to the complaint, WPATH removed age-based recommendations for certain transgender procedures from its Standards of Care. The FTC also alleges the organization promoted treatments that were not adequately supported by evidence regarding their safety and effectiveness.
The lawsuit, filed alongside Alaska, Iowa, Nebraska and Texas, marks the latest effort by President Donald Trump’s administration to scrutinize medical interventions for transgender minors.
WPATH previously sued to block an FTC investigation into the organization, arguing the agency violated its First Amendment rights. A federal judge in May temporarily blocked the probe.
WPATH rejected the allegations and said its standards are intended to support individualized patient care. In a statement provided to The Associated Press, the organization said its guidelines are based on individualized treatment rather than a “one-size-fits-all” approach.
Fox News Digital reached out to WPATH for additional comment but did not immediately receive a response.
“WPATH is in a strong position to prove that the FTC is acting out of pure retaliation as part of the federal government’s relentless and targeted campaign to undermine gender-affirming care by attacking the First Amendment rights and the independence of professional medical organizations,” the group said in a statement to the AP.
The lawsuit comes amid a broader national debate over puberty blockers, hormone therapies and sex change surgeries for minors.
Supporters argue the treatments can be medically necessary for some patients, while critics contend the long-term risks are not fully understood and that children may be unable to provide informed consent.
Leave a Reply